Established and emerging POCT approaches for kidney assessment in CKD are summarized, with emphasis on creatinine/eGFR and urine albumin-to-creatinine ratio (UACR), and analytical validity from workflow utility and patient-level clinical utility are distinguished.
Atthaphong Phongphithakchai, Kraiyasak Wongna, Ratana Netphakdee et al.· Medical Science· 0 citations
Overall, current evidence suggests that AM has preliminary renoprotective potential in experimental AKI models, however, the limited number of available studies, predominance of cisplatin-induced nephrotoxicity models, insufficient pharmacokinetic and safety data, and absence of human clinical studies preclude conclusi...
Atthaphong Phongphithakchai, Nawanwat C. Pattaranggoon, Kraiyasak Wongna et al.· Antioxidants· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.